Actions

CD13

From haematologyetc.co.uk

Revision as of 19:17, 26 April 2023 by John (talk | contribs)



Normal expression and function

CD13 is an enzyme which cleaves eutral amino acids from the N terminus of small peptides. The function of CD13 appears to vary with the tissue and the precise function in myeloid cells is unclear. The pattern of expression that is similar to other pan-myeloid markers (CD117 and CD33), but with levels generally increasing during maturation (contrasting with CD33 whose expression decreases). Maturation of myeloid cells may be partly identified through the relative CD33/13 expression.


Diagnostic role

  • Together with other markers (CD117, CD33 and MPO) CD13 identifies myeloid lineage, particularly acute myeloid leukaemia. CD13 is also found on myelomonocytic and monocytic leukaemias.
  • Expression is often absent on more primitive AML, erythroid or megakaryoblastic AML
  • Aberrant expression by ALL occurs in around 30% of patients (at the 20% threshold)
  • Overall high sensitivity, but may be less specific than CD117 or MPO.


Other relevant information:


Outside the haematopoietic system CD13 is particularly expressed on small intestinal and renal tubular epithelial cells and synaptic membranes from the CNS.




SUMMARY TABLES

Expression of CD13 by cells with early differentiation: ALL and haematogones
pro-B ALL early pre-B ALL pre-B ALL B-ALL pro T-ALL mat T-ALL AML Hgns
poss poss poss rare rare rare strg freq

* low expression correlates with subtype e.g. APML

Expression of CD38 by mature B cells: B-lymphoproliferative disorders
CLL MCL FL HCL HCv MZL LPL PCL
rare rare rare rare rare rare rare rare

*May indicate adverse prognostic when present on more than 20% of cells

**May be weak


1. Colour key: - the likelihood of any individual case expressing this marker, indicated by colour:

Rare (<5%) Possible (5-20%) Likely (20-40%) Frequent (40-80%) Expected (80-100%)

2. Text key: - where expression level is characteristic of a disorder this is indicated by text:

abs = absent expression, wk = weak expression, mod = moderate expression, stg = strong expression, sub = expression may be on a sub-population of cells

SUMMARY TABLES


Expression by acute leukaemias and by haematogones

Notes

In ALL the expression of CD13 is more likely in B-ALL but is also seen in T-ALL

In AML CD13 is expressed in around 80% of cases

In haematogones expression of CD13 is very frequent


Expression by B-lymphoproliferative disorders


Expression of CD13 by cells with early differentiation: ALL and haematogones
B ALL T ALL AML ETP ALL MPAL Hgns
rare freq strg strg freq
Expression of CD38 by mature B cells: B-lymphoproliferative disorders
CLL MCL FL HCL HCv MZL LPL PCL
rare rare rare rare rare rare rare rare



KEY


The indicated expression frequency, indicates the approximate frequency of occurrence in each particular disease type.


File:Rare.png

rare (<5%)

File:Poss.png

possible (5-20%)

File:Mod.png

likely (20-40%)

File:Freq.png

frequent (40-80%)

File:Hi.png

expected (>80%)


Where expression level is unusual or characteristic of a disorder this is indicated by text: